Grants for State governments - Health

The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) provides support for biologic-based therapeutic discovery and development, from lead optimization through phase I clinical testing. This Funding Opportunity Announcement (FOA) supports preclinical discovery and development of potential therapeutic Biotechnology Products and Biologics including, but not limited to, large biologic macromolecules, (e.g., proteins, antibodies, and peptides), gene-based therapies (i.e., oligonucleotide- and viral-based), cell therapies, and novel emerging therapies (e.g., microbial and microbiome therapies). Applicants will collaborate with NIH-funded consultants and can augment their project with NIH contract research organizations (CROs) that specialize in manufacturing, scaling, pharmacokinetics, toxicology, and Phase I clinical testing. BPN-Biologics awardee institutions retain their assignment of IP rights and gain assignment of IP rights from the BPN-Biologics contractors (and thereby control the patent prosecution and licensing negotiations) for biotherapeutic candidates developed in this program.

This funding opportunity supports small pilot projects that enhance understanding of the human virome, inviting collaborations from various organizations, including educational institutions and nonprofits, to develop innovative tools and methods for studying the interactions between viruses and human health.

The purpose of this notice of funding opportunity (NOFO) is to solicit applications proposing innovative transdisciplinary research that integrates approaches across social/cognitive neuroscience and other social sciences and will lead to a testable conceptual or computational model that provides mechanistic insights into social behavior and its relationships with the onset, trajectory and impact of Substance Use Disorders (SUD) and comorbidities. This NOFO is specifically soliciting applications proposing BESH research, referred to in NOT-OD-18-212 as prospective basic science studies involving human participants. These studies fall within the NIH definition of a clinical trial and also meet the definition of basic research. Application budgets are not limited but need to reflect the actual needs of the proposed project.

The "Short Courses on Utilizing the NIH Stage Model to Develop Behavioral Interventions to Promote Healthy Aging" grant aims to fund the creation of short educational programs that teach researchers how to use the NIH Stage Model to develop non-drug interventions that encourage healthy aging and improve care for older adults.

The "NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award (K01 Clinical Trial Not Allowed)" grant aims to provide financial support and entrepreneurial training to postdoctoral researchers and junior faculty in biomedical, social, or behavioral sciences, to foster their transition to research independence and potentially launch careers in industry, scientific business development, or academia, with a special focus on aging and Alzheimer's disease research.

This funding opportunity provides financial support to licensed organizations that offer long-term foster care and related services for unaccompanied minors without legal immigration status in the U.S.

This funding opportunity provides financial support for researchers to plan and prepare for clinical trials focused on infectious, immunologic, and allergic diseases, ensuring they have the necessary resources and documentation for future trial implementation.

This funding opportunity supports research initiatives aimed at preventing community violence among youth and young adults, particularly those addressing racial and ethnic disparities, with grants available to governments, educational institutions, and non-profits.

This grant provides funding to educational institutions to create programs that support and encourage undergraduate students from diverse and underrepresented backgrounds to pursue advanced degrees and careers in neuroscience research.

This funding opportunity supports postdoctoral researchers in biomedical and behavioral fields, providing mentorship and resources to help them develop into independent scientists.

This funding opportunity provides financial support to organizations working to improve HIV prevention and treatment for Haitian migrants and their descendants in the Dominican Republic, focusing on overcoming barriers to healthcare access and enhancing treatment outcomes.

This grant provides funding to support career development and mentoring for junior faculty in clinical rehabilitation fields, helping them transition to independent research roles that improve the health and quality of life for individuals with chronic disabilities.

This funding opportunity provides financial support for researchers to quickly evaluate new policies or programs aimed at influencing behaviors related to obesity, such as diet and physical activity, to help prevent or reduce obesity rates.

This grant provides funding to educational institutions and organizations to train professionals in vocational rehabilitation, specifically to support individuals who are hard of hearing, addressing workforce shortages in this field.

This grant provides funding for researchers to investigate the genetic and environmental causes of structural birth defects, promoting collaboration between scientists and clinicians to improve prevention and treatment strategies.

This funding opportunity provides financial support for organizations to implement school feeding programs and improve nutrition and education for children, particularly girls, in developing countries.

The "Tuberculosis Elimination and Laboratory Cooperative Agreement" is a CDC grant aimed at supporting state, local, and territorial health programs in their efforts to prevent, control, and eliminate tuberculosis in the U.S. through diagnosis, treatment, surveillance, and laboratory support, particularly in high-risk populations and regions with high TB burdens.

This funding opportunity supports high-risk, multi-center observational studies aimed at advancing research on diabetes, digestive diseases, kidney disorders, and other related health conditions, encouraging diverse institutions to collaborate and innovate.

This Notice of Funding Opportunity (NOFO) invites U24 Cooperative Agreement applications that propose to establish a national Open Measurement Coordinating Network for Non-Pharmacological Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Primary Prevention Trials. The Network will serve as a centralized hub for developing, validating, standardizing, and disseminating measures and measurement methods for AD/ADRD primary prevention trials. It will incorporate measures and measurement methods across neuropsychological, biomarker, and functional domains to meet the goal of primary prevention of AD/ADRD centered around brain health equity.

This funding opportunity supports doctoral candidates conducting research on substance use and substance use disorders, helping them complete their dissertation projects while fostering new talent in the field.